Opendata, web and dolomites

AbbVie Ltd (United Kingdom): list of projects

The following table shows the list of Horizon 2020 projects developed by "AbbVie Ltd". Projects are ordered by starting date.

Click on table headers to rearrange data.

# acronym  programme  role  EC contrib.  start  views 
1 ADAPT-SMART   H2020-EU.3.1.7.13. participant 0.00 2015-07-01 713
2 PREFER   H2020-EU.3.1.7. participant 0.00 2016-10-01 668
3 IMPRiND   H2020-EU.3.1.7. participant 0.00 2017-03-01 790
totale 0.00

Network analysis

This organization collaborated with partners in 12 countries.

 ADAPT-SMART

Within the project ADAPT-SMART this organization got in touch with:

role cy shortname name
participant CH SHIRE SHIRE INTERNATIONAL GMBH (PRC)
participant BE UCB UCB BIOPHARMA SRL (PRC)
participant IT AIFA AGENZIA ITALIANA DEL FARMACO (PRC)
participant FR Lysogene LYSOGENE (PRC)
participant BE EFPIA FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH)
participant UK Astellas ASTELLAS PHARMA EUROPE LTD (PRC)
participant NL ZIN ZORGINSTITUUT NEDERLAND (PUB)
participant FR IPSEN IPSEN INNOVATION SAS (PRC)
participant FR HAS HAUTE AUTORITE DE SANTE (PUB)
participant FR EURORDIS EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH)
participant US MSD MERCK SHARP & DOHME CORP (PRC)
participant UK NICE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB)
participant US BMS BRISTOL-MYERS SQUIBB COMPANY CORP (PRC)
participant BE Amgen AMGEN (PRC)
participant UK Eli Lilly Eli Lilly and Company Limited (PRC)
participant UK EMA THE EUROPEAN MEDICINES AGENCY (PUB)
coordinator NL LYGATURE STICHTING LYGATURE (OTH)
participant FR IRIS INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC)
participant DE Bayer Bayer Pharma AG (PRC)
participant US MIT MASSACHUSETTS INSTITUTE OF TECHNOLOGY (HES)
participant UK PFIZER PFIZER LIMITED (PRC)
participant FR SARD SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC)
participant DE BI BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC)
participant BE JANSSEN JANSSEN PHARMACEUTICA NV (PRC)
participant DK DHMA SUNDHEDSSTYRELSEN (PUB)
participant LU EPF FORUM EUROPEEN DES PATIENTS (FPE) (OTH)
participant CH ROCHE F. HOFFMANN-LA ROCHE AG (PRC)
participant CH NOVARTIS NOVARTIS PHARMA AG (PRC)
participant DK Lundbeck H. LUNDBECK AS (PRC)
participant UK GSK GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC)
participant DK Novo Nordisk NOVO NORDISK A/S (PRC)
participant SE MEDIMMUNE ASTRAZENECA AB (PRC)
participant DE Merck MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC)
participant UK UOXF THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES)

 PREFER

Within the project PREFER this organization got in touch with:

role cy shortname name
participant DE SPM STEINBEISSER PROJECT MANAGEMENT UG (HAFTUNGSBESCHRANKT) (PRC)
participant DE CSL CSL BEHRING GMBH (PRC)
participant UK MDUK MUSCULAR DYSTROPHY GROUP OF GREAT BRITAIN AND NORTHERN IRELAND (OTH)
participant BE MB MINDBYTES (PRC)
participant UK IAPO INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS (OTH)
participant UK Amgen AMGEN LIMITED (PRC)
participant BE KCE FEDERAAL KENNISCENTRUM VOOR DE GEZONDHEIDSZORG (REC)
participant UK Takeda TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC)
participant US MSD MERCK SHARP & DOHME CORP (PRC)
participant BE ECPC EUROPEAN CANCER PATIENT COALITION (OTH)
participant IT ITB "INSTITUTO TUMORI ""GIOVANNI PAOLO II""" (REC)
participant NL ASTELLAS ASTELLAS PHARMA EUROPE BV (PRC)
participant UK Lilly Eli Lilly and Company Limited (PRC)
participant DE Bayer Bayer Pharma AG (PRC)
participant UK Pfizer PFIZER LIMITED (PRC)
participant FR SANOFI SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC)
participant BE JP JANSSEN PHARMACEUTICA NV (PRC)
participant LU EPF FORUM EUROPEEN DES PATIENTS (FPE) (OTH)
participant CH ROCHE F. HOFFMANN-LA ROCHE AG (PRC)
participant CH NVS NOVARTIS PHARMA AG (PRC)
participant CH Actelion ACTELION PHARMACEUTICALS LTD (PRC)
participant NL ERASMUS ERASMUS UNIVERSITEIT ROTTERDAM (HES)
participant DE UKER UNIVERSITATSKLINIKUM ERLANGEN (HES)
participant UK UoB THE UNIVERSITY OF BIRMINGHAM (HES)
participant NL UMCU UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES)
participant SE MEDIMMUNE ASTRAZENECA AB (PRC)
participant DE Merck MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC)
participant IT IEO ISTITUTO EUROPEO DI ONCOLOGIA SRL (PRC)
coordinator SE UU UPPSALA UNIVERSITET (HES)
participant UK UNEW UNIVERSITY OF NEWCASTLE UPON TYNE (HES)
participant NL EMC ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES)
participant BE KUL KATHOLIEKE UNIVERSITEIT LEUVEN (HES)

 IMPRiND

Within the project IMPRiND this organization got in touch with:

role cy shortname name
participant UK NERC-BAS UNITED KINGDOM RESEARCH AND INNOVATION (REC)
participant FR UBx UNIVERSITE DE BORDEAUX (HES)
participant DE DZNE DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV (REC)
participant UK Eli Lilly Eli Lilly and Company Limited (PRC)
participant BE JANSSEN JANSSEN PHARMACEUTICA NV (PRC)
participant DE UMG-GOE UNIVERSITAETSMEDIZIN GOETTINGEN - GEORG-AUGUST-UNIVERSITAET GOETTINGEN - STIFTUNG OEFFENTLICHEN RECHTS (HES)
participant EL BRFAA IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON (REC)
participant BE VIB VIB VZW (REC)
participant CH SCIPROM SCIPROM SARL (PRC)
participant CH NOVARTIS NOVARTIS PHARMA AG (PRC)
participant DK Lundbeck H. LUNDBECK AS (PRC)
participant FR Servier INSTITUT DE RECHERCHES SERVIER (PRC)
participant UK UNIVDUN UNIVERSITY OF DUNDEE (HES)
participant UK UCAM THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES)
coordinator UK UOXF THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES)
participant UK MRC MEDICAL RESEARCH COUNCIL (REC)
participant DK AU AARHUS UNIVERSITET (HES)
participant FR CNRS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS (REC)